A nurse is reinforcing education with a client who has type 1 diabetes mellitus and has been experiencing hypoglycemic episodes. Which of the following statements by the nurse is appropriate?

Hypoglycemia is an acute metabolic complication characterized by plasma glucose concentrations <3.9 mmol/L, triggering neurogenic and neuroglycopenic cascades. The condition stems from an imbalance between exogenous insulin administration, carbohydrate intake, and energy expenditure. Autonomic counter-regulatory responses cause diaphoresis, tachycardia, altered mentation, and seizures if left unmanaged. A. "Clients will usually have obvious manifestations of hypoglycemia.": Autonomic neuropathy secondary to longstanding diabetes mellitus often suppresses the typical adrenergic warning signs. This physiological state, known as hypoglycemia unawareness, masks initial neurogenic indicators like tremors or palpitations. The absence of symptoms delays critical patient recognition and self-treatment. B. "Keeping supplies on hand to treat hypoglycemic episodes is important.": Immediate access to fast-acting carbohydrates ensures rapid reversal of declining systemic glucose concentrations. This oral intervention prevents the progression of neuroglycopenia toward central nervous system depression. Maintaining rescue supplies minimizes the risk of severe cognitive impairment or comatose states. C. "Increasing exercise can help with hypoglycemia.": Physical exertion increases skeletal muscle glucose uptake via insulin-independent GLUT4 transporter translocation. This metabolic activity accelerates plasma glucose clearance and exacerbates existing deficits in circulating substrates. Enhanced energy expenditure without corresponding caloric compensation worsens the severity of the drop. D. "Clients with hypoglycemia cannot participate in religious/cultural fasting.": Patients managing volatile glucose levels can safely engage in modified fasting through structured medical guidance. Comprehensive pharmacological titration, continuous interstitial glucose monitoring, and individualized dietary adjustments facilitate safe participation. Strict prohibition overlooks clinical risk-stratification models and personalized endocrinology management plans.